BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11745003)

  • 21. Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.
    Amiri F; Venema VJ; Wang X; Ju H; Venema RC; Marrero MB
    J Biol Chem; 1999 Nov; 274(45):32382-6. PubMed ID: 10542280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.
    Madonna R; De Caterina R
    Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the JAK/STAT signaling pathway in diabetic nephropathy.
    Marrero MB; Banes-Berceli AK; Stern DM; Eaton DC
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F762-8. PubMed ID: 16527921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
    Fiorentino TV; Prioletta A; Zuo P; Folli F
    Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II-induced signaling pathways in diabetes.
    Marrero MB; Fulton D; Stepp D; Stern DM
    Curr Diabetes Rev; 2005 May; 1(2):197-202. PubMed ID: 18220595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy.
    Haller H; Drab M; Luft FC
    Clin Nephrol; 1996 Oct; 46(4):246-55. PubMed ID: 8905209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology.
    Manna P; Sil PC
    Free Radic Res; 2012 Jul; 46(7):815-30. PubMed ID: 22486656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorder of vascular smooth muscle cell and platelet function in diabetes].
    Goto H; Watada H
    Nihon Rinsho; 2010 May; 68(5):833-8. PubMed ID: 20446578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of hyperglycemia in the development of diabetic microangiopathy].
    Miyata S; Kasuga M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():45-51. PubMed ID: 15999684
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemistry and molecular cell biology of diabetic complications.
    Brownlee M
    Nature; 2001 Dec; 414(6865):813-20. PubMed ID: 11742414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperglycemia stimulates p62/PKCζ interaction, which mediates NF-κB activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle.
    Xi G; Shen X; Wai C; Vilas CK; Clemmons DR
    FASEB J; 2015 Dec; 29(12):4772-82. PubMed ID: 26231202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is methylglyoxal a causative factor for hypertension development?
    Wu L
    Can J Physiol Pharmacol; 2006 Jan; 84(1):129-39. PubMed ID: 16845897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Glucose Levels Promote Contractile and Cytoskeletal Gene Expression in Vascular Smooth Muscle via Rho/Protein Kinase C and Actin Polymerization.
    Hien TT; Turczyńska KM; Dahan D; Ekman M; Grossi M; Sjögren J; Nilsson J; Braun T; Boettger T; Garcia-Vaz E; Stenkula K; Swärd K; Gomez MF; Albinsson S
    J Biol Chem; 2016 Feb; 291(7):3552-68. PubMed ID: 26683376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?
    Bursell SE; King GL
    Diabetes Res Clin Pract; 1999 Sep; 45(2-3):169-82. PubMed ID: 10588370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.
    Evans JL; Goldfine ID; Maddux BA; Grodsky GM
    Endocr Rev; 2002 Oct; 23(5):599-622. PubMed ID: 12372842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway.
    Hall JL; Matter CM; Wang X; Gibbons GH
    Circ Res; 2000 Sep; 87(7):574-80. PubMed ID: 11009562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus.
    Ishii H; Koya D; King GL
    J Mol Med (Berl); 1998 Jan; 76(1):21-31. PubMed ID: 9462865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium and diabetic vascular dysfunction. Focus on "Elevated Ca(2+) sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells".
    Dunn KM; Nelson MT
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C203-5. PubMed ID: 19907015
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms of diabetic complications.
    Aleksandrovski YA
    Biochemistry (Mosc); 1998 Nov; 63(11):1249-57. PubMed ID: 9864462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperglycemia increases vascular adrenomedullin expression.
    Hayashi M; Shimosawa T; Fujita T
    Biochem Biophys Res Commun; 1999 May; 258(2):453-6. PubMed ID: 10329408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.